Methicillin-Resistant Staphylococcus Aureus Clinical Trial
Official title:
Comparison of Decolonization of MRSA Using Theraworx
The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.
Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05529173 -
Povidone-Iodine for Nasal Decolonization
|
Phase 4 | |
Completed |
NCT00980980 -
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
|
N/A | |
Recruiting |
NCT03412500 -
Vancomycin Dosage Adjustment for MRSA Infections
|
Phase 4 | |
Recruiting |
NCT02566928 -
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
|
Phase 4 | |
Terminated |
NCT01196169 -
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT00996112 -
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
|
N/A | |
Not yet recruiting |
NCT00773864 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
|
N/A | |
Not yet recruiting |
NCT00773799 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
|
N/A | |
Completed |
NCT01350479 -
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
|
N/A | |
Recruiting |
NCT03637400 -
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
|
Phase 2 | |
Completed |
NCT01200654 -
Population Pharmacokinetics of Linezolid
|
Phase 4 | |
Withdrawn |
NCT00856089 -
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
|
Phase 4 | |
Recruiting |
NCT04171817 -
Animal-Assisted Visitation Program Chlorhexidine Trial
|
Phase 4 | |
Completed |
NCT00324922 -
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
|
Phase 3 | |
Completed |
NCT02814916 -
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
|
Phase 3 | |
Not yet recruiting |
NCT05632315 -
PMT for MDRO Decolonization
|
Phase 2 | |
Not yet recruiting |
NCT01356472 -
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
|
Phase 4 | |
Completed |
NCT03886623 -
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
|
N/A | |
Completed |
NCT01138462 -
Control of MRSA in Nursing Homes: Decolonization vs Standard Precautions
|
N/A | |
Completed |
NCT01141101 -
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
|
N/A |